Artificial Intelligence-assisted Confocal Laser Endomicroscopy Identification of Intestinal Metaplasia Severity
1 other identifier
observational
1,000
1 country
1
Brief Summary
Currently, the Correa cascade is a widely accepted model of gastric carcinogenesis. Intestinal metaplasia is a high risk factor for gastric cancer. According to Sydney criteria, mild intestinal metaplasia was not associated with gastric cancer, while moderate to severe intestinal metaplasia was strongly associated with the development of gastric cancer. Because intestinal metaplasia is distributed in various forms, the use of white light endoscopy lacks specificity, and the consistency with histopathological diagnosis is poor; Pathological biopsy is still needed to make a diagnosis. At present, national guidelines suggest that OLGIM score should be used to evaluate the risk of gastric cancer, and patients with OLGIM grade III/IV should be monitored by close gastroscopy. However, it requires at least four biopsies, which is clinically infeasible. Confocal laser endomicroscopy allows real-time observation of living tissue, comparable to pathological findings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 9, 2022
CompletedFirst Posted
Study publicly available on registry
July 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJuly 18, 2022
July 1, 2022
1.5 years
July 9, 2022
July 13, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Accuracy of AI model in assessing degree of intestinal metaplasia
Pathological biopsy results were used as the gold standard to assess the accuracy of the AI model in diagnosing the degree of intestinal metaplasia at the biopsy site
2 years
Sensitivity of AI model to assess degree of intestinal metaplasia
The sensitivity of the AI model to diagnose the degree of intestinal metaplasia at the biopsy site was assessed using pathological biopsy results as the gold standard
2 years
Specificity of AI model to assess degree of intestinal metaplasia
Pathological biopsy results were used as the gold standard to assess the specificity of the AI model in diagnosing the degree of intestinal metaplasia at the biopsy site
2 years
Study Arms (2)
group for training the algorithm
This group of images is used for training the algorithm of the artifical intelligence
group for testing the algorithm
This group of images is used for testing the algorithm of the artifical intelligence
Eligibility Criteria
Consecutive patients who receive the upper gastrointestinal tract pCLE examination and screened that fulfill the eligibility criteria at Qilu Hospital, Shandong University will be enrolled into the study.
You may qualify if:
- Patients aged 18-80 years undergoing confocal gastroscopy
You may not qualify if:
- Patients with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who cannot participate in gastroscopy
- Patients with previous surgical procedures on the stomach
- Patients with contraindications to biopsy
- Patients who refuse to sign the informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qilu Hospital, Shandong University
Jinan, Shandong, 250001, China
Biospecimen
When a gastric mucosal leison is found using white light endoscopy, endoscopist will observe this lesion using pCLE and then take biopsy for histology examination.
Study Officials
- PRINCIPAL INVESTIGATOR
Yanqing Li
Qilu Hospital of Shandong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice President of Qilu Hospital
Study Record Dates
First Submitted
July 9, 2022
First Posted
July 18, 2022
Study Start
July 1, 2022
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
July 18, 2022
Record last verified: 2022-07